top of page
Search
IN VITRO REVOLUTION
Alzheimer's Disease
Idiopathic Pulmonary Fibrosis
Congenital Heart Disease
Type 1 Diabetes Mellitus
Inflammatory Bowel Disease
Amyotrophic Lateral Sclerosis
Thrombocytopenia
Chronic Skin Wounds
INDUSTRY NEWS
Product Launches
Intra-industry Partnerships
M&A Activity
Grants Awarded & Funds Raised
Pharma & Biotech Collaborations
Clinical Trial Authorizations
Regulatory Modernization
TECH FRONTIERS
APPLICATION EXPLORER
Log In
Subscribe to Newsletter
All Posts
Organ-on-a-chip systems
Intra-industry partnerships
Pharma & biotech collaborations
Product Launches
Clinical Trial Outcomes
M&A Activity
Bioprinting
3D tissue platforms
Clinical Trial Authorizations
Regulatory Modernizations
Organoid technologies
Grants Awarded & Funds Raised
Hybrid AI-in vitro platforms
Organoid technologies
Explores current advances in organoid‑engineering technologies
Bioengineered directoids enable in vitro probing of information flow between human brain regions
Organoid technologies
Human sympathetic ganglion organoids support investigation of sympathetic innervation of target organs
Organoid technologies
Autologous human tumor-immune organoid model for patient-specific prediction of response to immunotherapy
Organoid technologies
Immune-competent human liver organoids model adaptive immunity-mediated idiosyncratic DILI
Organoid technologies
Multi-region brain organoids for unprecedented insights into human neurodevelopmental disorders
Organoid technologies
bottom of page